Evaluation of Concepts for Mulitiple Application Thermal Reactor for Irradiation eXperiments (MATRIX)

The Advanced Test Reactor (ATR) is a high power density test reactor specializing in fuel and materials irradiation. For more than 45 years, the ATR has provided irradiations of materials and fuels testing along with radioisotope production. Originally operated primarily in support of the Offcie of Naval Reactors (NR), the mission has gradually expanded to cater to other customers, such as the DOE Office of Nuclear Energy (NE), private industry, and universities. Unforeseen circumstances may lead to the decommissioning of ATR, thus leaving the U.S. Government without a large-scale materials irradiation capability to meet the needs of its nuclear energy and naval reactor missions. In anticipation of this possibility, work was performed under the Laboratory Directed Research and Development (LDRD) program to investigate test reactor concepts that could satisfy the current missions of the ATR along with an expanded set of secondary missions. This work can be viewed as an update to a project from the 1990’s called the Broad Application Test Reactor (BATR). In FY 2012, a survey of anticipated customer needs was performed, followed by analysis of the original BATR concepts with fuel changed to low-enriched uranium. Departing from these original BATR designs, four concepts were identified for further analysis in FY2013. The project informally adopted the acronym MATRIX (Multiple-Application Thermal Reactor for Irradiation eXperiments). This report discusses analysis of the four MATRIX concepts along with a number of variations on these main concepts. Designs were evaluated based on their satisfaction of anticipated customer requirements and the “Cylindrical” variant was selected for further analysis of options. This downselection should be considered preliminary and the backup alternatives should include the other three main designs. The baseline Cylindrical MATRIX design is expected to be capable of higher burnup than the ATR (or longer cycle length given a particular batch scheme). The volume of test space in IPTs is larger in MATRIX than in ATR with comparable magnitude of neutron flux. In addition to the IPTs, the Cylindrical MATRIX concept features test spaces at the centers of fuel assemblies where very high fast flux can be achieved. This magnitude of fast flux is similar to that achieved in the ATR A-positions, however, the available volume having these conditions is greater in the MATRIX design than in the ATR. From the analyses performed in this work, it appears that the Cylindrical MATRIX design can be designed to meet the anticipated needs of the ATR replacement reactor. However, this statement must be qualified by acknowledging that this design is quite immature, and therefore any requirements currently met must be re-evaluated as the design matures. Also, some of the requirements were not strictly met, but are believed to be achievable once features to be added later are designed

Genetic Ablation of Pannexin1 Protects Retinal Neurons from Ischemic Injury

Pannexin1 (Panx1) forms large nonselective membrane channel that is implicated in paracrine and inflammatory signaling. In vitro experiments suggested that Panx1 could play a key role in ischemic death of hippocampal neurons. Since retinal ganglion cells (RGCs) express high levels of Panx1 and are susceptible to ischemic induced injury, we hypothesized that Panx1 contributes to rapid and selective loss of these neurons in ischemia. To test this hypothesis, we induced experimental retinal ischemia followed by reperfusion in live animals with the Panx1 channel genetically ablated either in the entire mouse (Panx1 KO), or only in neurons using the conditional knockout (Panx1 CKO) technology. Here we report that two distinct neurotoxic processes are induced in RGCs by ischemia in the wild type mice but are inactivated in Panx1KO and Panx1 CKO animals. First, the post-ischemic permeation of RGC plasma membranes is suppressed, as assessed by dye transfer and calcium imaging assays ex vivo and in vitro. Second, the inflammasome-mediated activation of caspase-1 and the production of interleukin-1β in the Panx1 KO retinas are inhibited. Our findings indicate that post-ischemic neurotoxicity in the retina is mediated by previously uncharacterized pathways, which involve neuronal Panx1 and are intrinsic to RGCs. Thus, our work presents the in vivo evidence for neurotoxicity elicited by neuronal Panx1, and identifies this channel as a new therapeutic target in ischemic pathologies

Safety Requirements, Facility User Needs, and Reactor Concepts for a New Broad Application Test Reactor

This report describes the EG G Laboratory Directed Research and Development Program (LDRD) Broad Application Test Reactor (BATR) Project that was conducted in fiscal year 1991. The scope of this project was divided into three phases: a project process definition phase, a requirements development phase, and a preconceptual reactor design and evaluation phase. Multidisciplinary teams of experts conducted each phase. This report presents the need for a new test reactor, the project process definition, a set of current and projected regulatory compliance and safety requirements, a set of facility user needs for a broad range of projected testing missions, and descriptions of reactor concepts capable of meeting these requirements. This information can be applied to strategic planning to provide the Department of Energy with management options